Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES Share Price    (VSRM)

Here is the latest stock price and chart of VENUS REMEDIES. For more details, see the VENUS REMEDIES company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Learn: How to Potentially Accumulate Rs 7 Crore in Wealth Over the Long-term

REFRESH
Live BSE Quotes May 14, 2021 03:37:00 PM
Price (Rs)312.00 Open (Rs) 314.05 High (Rs) 324.00 Low (Rs) 309.85
% Change-1.02 Volume 6,281 Value (Rs) 1,959,672 52-Week H/L 352.55 / 42.80
Live NSE Quotes May 14, 2021 3:29:56 PM
Price (Rs)313.45 Open (Rs) 315.50 High (Rs) 328.85 Low (Rs) 308.15
% Change-0.70 Volume 49,143 Value (Rs) 15,610,274 52-Week H/L 353.75 / 43.45
Change
1 Day
-1.02%
1 Month
9.55%
3 Months
65.96%
1 Year
494.85%
5 Years (CAGR)*
29.90%
10 Years (CAGR)*
4.40%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* -21.14 P/E Ratio (x) NM Market Cap (Rs m) 3,569.28 P/BV (x) 0.99
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

VENUS REMEDIES Share Price Today:

VENUS REMEDIES last traded price was down 1.0% to Rs 312.0 on the BSE. On the NSE, VENUS REMEDIES last traded price was down 0.7% to Rs 313.5. The total volume of shares traded was 0.1 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 1.2%. And the benchmark S&P BSE SENSEX was at 48,732.6 (up 0.1%).

Over the last 30 days, the VENUS REMEDIES share price is up 13.1%. And over the last one year, VENUS REMEDIES share price is up 410.2%.



What else is happening in the markets today? Dig in...


Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, VENUS REMEDIES has posted a net profit of Rs 104 m (down 11.1% YoY). Sales on the other hand came in at Rs 864 m (down 7.3% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

More Views on News

Most Popular

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Worst Sector in the Market (Fast Profits Daily)

May 11, 2021

The worst sector in the stock market according to the charts.

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK VENUS REMEDIES

  • Track your investment in VENUS REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VENUS REMEDIES

VENUS REMEDIES - ADCOCK INGRAM COMPARISON

COMPARE VENUS REMEDIES WITH

MARKET STATS